Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS)
Related Posts
Milan G, Mareninova OA, Fantuz M, Spacci M, Paoli C, Pineda JA, Noè R, Calciolari B, Zoncu R, Gukovskaya AS, Carrer A. Reprogramming of cholesterol[...]
Schmolly K, Rudrapatna V, Beaven S. Recommendations for recognizing and diagnosing Acute Hepatic Porphyria in atypical patient populations. Orphanet J Rare Dis. 2025 Oct 24;20(1):539.[...]
Végh ET, Balla Z, Dágó Á, Salamah O, Tóth B, Elperin J, Speakman S, Shalbueva N, Pallagi P, Rázga Z, Kiss L, Gukovskaya A, Rakonczay[...]